Narasimha Kumar, Chief Product Officer at Datafoundry, delivered an engaging presentation titled “AI in Drug […]

In the world of safety vigilance, the meticulous task of literature surveillance is crucial for […]

We’re down to Days (No More Delays)  In this Datafoundry Blog, we bring you a […]

Efficiency of case intake is critical to safety vigilance operations. However, the conventional approach of […]

Safety concerns associated with therapeutic intervention(s) and immunizations can be detected, analyzed, and minimized only […]

The healthcare landscape is a dynamic ecosystem, constantly growing with new drugs, cosmetics, nutraceuticals, and […]

In the past few years, the domain of Pharmacovigilance (PV) (incl. Cosmetovigilance and Materiovigilance) has […]

In the rapidly evolving landscape of pharmacovigilance (PV), ensuring patient safety and health outcomes is […]

The challenges of Safety Vigilance in Pharma, Cosmetics, Devices, Vaccines and Nutraceuticals are creating a […]

Navigating the Tsunami of Data According to a recent report by Arcadia Approximately 30% of […]

In the highly regulated landscape of pharmacovigilance (PV), ensuring patient safety and health outcomes is […]

The pharmaceutical industry is advancing at an unprecedented pace, with new drugs and therapies continually […]

Introduction Identifying adverse events from medical literature is one of the key tasks in pharmacovigilance […]

In the fast-evolving landscape of pharmacovigilance, staying ahead of potential adverse events (AEs) and ensuring […]

Patient safety is of the utmost significance in the healthcare industry across the world. Every […]

Cosmetovigilance is a field that deals with monitoring and evaluating the safety of cosmetic products. […]

The pharmaceutical sector has grown significantly in recent years as a result of digitization and […]

We are thrilled to announce the launch of DF mSignal AI, a cutting-edge signal management […]